Clinical trials recruiting in Metz, France

Phase breakdown

Conditions recruiting in Metz, France

Recruiting trials in Metz, France

• A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)
  NCT06053099 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
  NCT05774951 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU
  NCT05475600 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Real-World Context
  NCT06487078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• BIO|STREAM.CSP Study
  NCT07393009 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy
  NCT04638088 · Phase: Not specified · Ages: 18 Years and older · Sex: Male
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Dat'Aids Prevention
  NCT03795376 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
  NCT05255302 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female)
• Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
  NCT05732727 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Quality of Care in French HIV Infected Patients
  NCT02898987 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
  NCT06425133 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
  NCT06726720 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Metz, France?

13 recruiting trials have at least one study site in Metz, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.